It’s the simple additions to your service that improve patient satisfaction, start offering medicines delivery to all of them today
Looking for Rybelsus for weight loss in the UK?
Rybelsus contains semaglutide, but it is licensed for type 2 diabetes, not weight loss. If you are looking for semaglutide tablets for weight management, Wegovy tablets are the licensed UK option for eligible adults after a clinical assessment.
All weight loss treatments
Shop all treatments→Wegovy weight loss
Shop Wegovy Pill (semaglutide)→
Rybelsus is a licensed medicine in the UK for treating type 2 diabetes. It is not licensed as a UK weight loss treatment.
Although Rybelsus and Wegovy tablets both contain semaglutide, they are not used in the same way. Rybelsus is used for diabetes management, while Wegovy tablets are licensed for weight loss and weight management in eligible adults.
If you are looking for tablet-based weight loss treatment, you should choose a licensed weight management option after a proper clinical review.
Wegovy tablets are the licensed semaglutide tablet option for weight loss and weight management in eligible adults. They are prescription-only and should only be used where a clinician decides they are suitable for you.
Your suitability may depend on your BMI, medical history, current medicines, treatment goals and whether a tablet option is appropriate for you.
Both medicines contain semaglutide. The key difference is what they are licensed and prescribed for in the UK.
No GP visit needed. Complete your request online and have your answers reviewed by a qualified prescriber.
Start from the weight loss treatment page and complete a short online consultation about your health, BMI and treatment preferences.
A qualified prescriber reviews your answers to check whether treatment is suitable and safe for you.
If approved, your treatment is dispensed and delivered in discreet, unmarked packaging.
No. Rybelsus and Wegovy tablets both contain semaglutide, but they are not the same treatment.
Rybelsus is licensed for adults with type 2 diabetes. Wegovy tablets are licensed for weight loss and weight management in eligible adults.
Rybelsus is not licensed as a UK weight loss treatment. It is a diabetes medicine, so it should not be supplied as a private weight loss treatment.
If you are looking for semaglutide tablets for weight management, Wegovy tablets are the licensed treatment option for eligible adults after a clinical assessment.
Wegovy tablets are used for weight management because they are licensed for that purpose. They contain semaglutide, like Rybelsus, but are intended for weight loss and weight maintenance in eligible adults.
Rybelsus is intended for type 2 diabetes management, so it is not the right treatment route for people seeking weight loss treatment only.
Yes. Wegovy tablets are a licensed semaglutide tablet option for weight loss and weight management in eligible adults.
They are prescription-only, so you will need a clinical assessment before treatment can be supplied.
Yes. Semaglutide weight loss treatments are prescription-only medicines. You will need to complete a clinical assessment so a qualified prescriber can check whether treatment is suitable and safe for you.
This helps check your BMI, medical history, current medicines and any risk factors that may affect whether treatment is appropriate.
Other licensed weight loss treatments may include Mounjaro, Saxenda, Mysimba, Orlistat and Xenical, depending on your suitability and availability.
The right option depends on your BMI, medical history, current medicines, treatment preferences and the outcome of your clinical assessment.
Rybelsus is not licensed as a UK weight loss treatment.
Complete a short online consultation to explore licensed weight loss treatment options, including tablet-based options where suitable.
It’s the simple additions to your service that improve patient satisfaction, start offering medicines delivery to all of them today